We therefore provide clinical evidence from the GEPIA, TCGA data set and our patient cohort, indicating that high EZH2 expression strongly correlates with increased tumor nodules numbers, enhanced tumor size, advanced TNM stage, high pathological grade and increased relapse as well as increased venous invasion, vascular tumor thrombus, and liver capsule invasion. This evidence concerns the gene EZH2 and neoplasm.